Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy
ClinicalTrials.gov study NCT06503276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma
ClinicalTrials.gov study NCT01189383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT05940051. IPD Sharing: NO. Countries: 1. Publications: 0.
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT06300528. IPD Sharing: NO. Countries: 1. Publications: 0.
CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04156178. IPD Sharing: NO. Countries: 1. Publications: 0.
Occurrence of Acute Kidney Injury After CAR-T Cells Treatments in B-cell Lymphoma.
ClinicalTrials.gov study NCT07101913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00026182. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas
ClinicalTrials.gov study NCT01897012. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study Evaluating the Safety and Efficacy of BAFFR CAR-T Therapy for Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT07345728. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT01926665. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
ClinicalTrials.gov study NCT00290667. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Natural Killer (NK) Cell Therapy for B-Cell Malignancies
ClinicalTrials.gov study NCT05379647. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00289562. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
ClinicalTrials.gov study NCT01040039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Trial of ONC-PluReceptor NK Cells With Epcoritamab and Tafasitamab for Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07283679. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GC022 CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
ClinicalTrials.gov study NCT03825731. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma
ClinicalTrials.gov study NCT04648475. IPD Sharing: NO. Countries: 1. Publications: 0.
Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
ClinicalTrials.gov study NCT05270057. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Sub
ClinicalTrials.gov study NCT05206357. IPD Sharing: NO. Countries: 14. Publications: 0.
Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT04668365. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.